Imaging the limbic system in Parkinson's disease—a review of limbic pathology and clinical symptoms
M Banwinkler, H Theis, S Prange, T van Eimeren - Brain sciences, 2022 - mdpi.com
The limbic system describes a complex of brain structures central for memory, learning, as
well as goal directed and emotional behavior. In addition to pathological studies, recent …
well as goal directed and emotional behavior. In addition to pathological studies, recent …
Morphological basis of Parkinson disease-associated cognitive impairment: an update
KA Jellinger - Journal of Neural Transmission, 2022 - Springer
Cognitive impairment is one of the most salient non-motor symptoms of Parkinson disease
(PD) that poses a significant burden on the patients and carers as well as being a risk factor …
(PD) that poses a significant burden on the patients and carers as well as being a risk factor …
Pathobiology of cognitive impairment in Parkinson disease: challenges and outlooks
KA Jellinger - International Journal of Molecular Sciences, 2023 - mdpi.com
Cognitive impairment (CI) is a characteristic non-motor feature of Parkinson disease (PD)
that poses a severe burden on the patients and caregivers, yet relatively little is known about …
that poses a severe burden on the patients and caregivers, yet relatively little is known about …
The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study
Abstract Dementia in Lewy Body Diseases (Parkinson's disease and dementia with Lewy
Bodies) affects progression of disabilities, quality of life and well-being. Understanding its …
Bodies) affects progression of disabilities, quality of life and well-being. Understanding its …
A systematic review of brain morphometry related to deep brain stimulation outcome in Parkinson's disease
F Wang, Y Lai, Y Pan, H Li, Q Liu, B Sun - npj Parkinson's Disease, 2022 - nature.com
While the efficacy of deep brain stimulation (DBS) is well-established in Parkinson's Disease
(PD), the benefit of DBS varies across patients. Using imaging features for outcome …
(PD), the benefit of DBS varies across patients. Using imaging features for outcome …
Fine‐grained features characterize hippocampal and amygdaloid change pattern in Parkinson's disease and discriminate cognitive‐deficit subtype
L Zhang, P Zhang, Q Dong, Z Zhao… - CNS Neuroscience …, 2024 - Wiley Online Library
Aims To extract vertex‐wise features of the hippocampus and amygdala in Parkinson's
disease (PD) with mild cognitive impairment (MCI) and normal cognition (NC) and further …
disease (PD) with mild cognitive impairment (MCI) and normal cognition (NC) and further …
Dose and time-dependence of acute intermittent theta-burst stimulation on hippocampus-dependent memory in parkinsonian rats
Y Wang, J Liu, Y Hui, Z Wu, L Wang, X Wu… - Frontiers in …, 2023 - frontiersin.org
Background The treatment options for cognitive impairments in Parkinson's disease (PD) are
limited. Repetitive transcranial magnetic stimulation has been applied in various …
limited. Repetitive transcranial magnetic stimulation has been applied in various …
Magnetic resonance imaging markers for cognitive impairment in Parkinson's disease: current view
Y Hou, H Shang - Frontiers in aging neuroscience, 2022 - frontiersin.org
Cognitive impairment (CI) ranging from mild cognitive impairment (MCI) to dementia is a
common and disturbing complication in patients with Parkinson's disease (PD). Numerous …
common and disturbing complication in patients with Parkinson's disease (PD). Numerous …
磁共振NODDI 技术在帕金森认知障碍患者海马微观结构的应用
肖宁, 热米拉, 玉山, 陆鹏, 姜磊, 王红 - 分子影像学杂志, 2022 - j-fzyx.com
目的利用神经突方向离散度与密度成像(NODDI) 探索帕金森认知障碍(PD-CI)
患者海马微观结构的变化, 并探讨其与认知功能的关系. 方法选择我院36 例帕金森病患者为帕 …
患者海马微观结构的变化, 并探讨其与认知功能的关系. 方法选择我院36 例帕金森病患者为帕 …
[HTML][HTML] Morphological changes in Parkinson's disease based on magnetic resonance imaging: A mini-review of subcortical structures segmentation and shape …
JH Deng, HW Zhang, XL Liu, HZ Deng… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is a neurodegenerative disorder caused by the loss of
dopaminergic neurons in the substantia nigra, resulting in clinical symptoms, including …
dopaminergic neurons in the substantia nigra, resulting in clinical symptoms, including …